Catalog Number 405672 |
Device Problem
Defective Component (2292)
|
Patient Problem
Therapeutic Effects, Unexpected (2099)
|
Event Date 04/16/2019 |
Event Type
Injury
|
Manufacturer Narrative
|
Medical device expiration date: unknown.Pma / 510(k)#: enforcement discretion.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.Device manufacture date: unknown.
|
|
Event Description
|
It was reported that during use of the tray spn whit25g3.5 l/b-d/e blue drape the bupivacaine did not work and the patients had to be converted to general anesthesia.Material no.: 405672 batch: unknown.The following information was provided by the initial reporter: for patient (b)(4).Per email: a patient was to undergo spinal anesthesia as primary anesthesia, but was still able to move their leg.Staff had to convert to general anesthesia.Similar results with multiple cases on the same day.
|
|
Manufacturer Narrative
|
Investigation: although a lot number was not provided for this particular complaint it is suspected that the lot number may be identical to a similar complaint (lot # 0001275590) since both complaints were reported at the same time by the same customer.A dhr review of all applicable manufacturing records for lot 0001275590 did not identify any issues that may have contributed to the reported failure mode.Although a complaint sample was not provided for this complaint it is suspected that the samples provided for a similar complaint are of particular significance (same suspected lot, same end user).The investigation could not confirm the failure mode for the samples provided for pr-919315.All thirteen (13) trays were opened and each bupivacaine vail was visually inspected for obvious defect.No defects were observed.Liquid within each vial was clear and without any visible particulate matter.The investigation was not able to identify or confirm any contribution to the reported failure mode from the factors noted above.Specific to the handling of the drugs, the investigation noted specific procedures to control the handling of any raw material drug component during the receipt, storage, and use in the manufacturing process.A review of the temperature monitoring system within the mannford facility did not identify any excursions that would have negatively affected any of the raw material drug components used within this product code.The investigation did identify this failure mode as a previously known issue.Based on the complaint investigation, a probable root cause could not be identified for the reported failure mode.The investigation identified a previous capa (capa 67717) performed by the bd anesthesia quality group that specifically investigated the ¿ineffective anesthesia¿ failure mode.Refer to capa 67717 for additional information regarding the outcome of the investigation.Likewise, the investigation identified a summary for previously investigated complaints (pic: ms-002-pic) which provides rationale and information regarding the potential ineffective anesthesia outcome during the use of an anesthesia product code.Based on a review of all of these sources, the current complaint investigation could not identify a definitive root cause nor could any potential contributor be identified for this specific complaint failure mode.
|
|
Event Description
|
It was reported that during use of the tray spn whit25g3.5 l/b-d/e blue drape the bupivacaine did not work and the patients had to be converted to general anesthesia.Material no.: 405672.Batch: unknown.The following information was provided by the initial reporter: for patient 0760 (5/5) per email: a patient was to undergo spinal anesthesia as primary anesthesia, but was still able to move their leg.Staff had to convert to general anesthesia.Similar results with multiple cases on the same day.
|
|
Search Alerts/Recalls
|